收藏切换
Retrospectively analysis on rivaroxaban on outcomes of in elderly patients with atrial fibrillation and stable coronary artery disease
收藏切换
Yuhui CHU, Yaowu ZUO, Dianfu ZHANG
World Clinical Drug | 2023, 44(5) : 499 - 505
Less
收藏切换
World Clinical Drug | 2023, 44(5): 499-505
• Article •
Retrospectively analysis on rivaroxaban on outcomes of in elderly patients with atrial fibrillation and stable coronary artery disease
Full
Yuhui CHU, Yaowu ZUO, Dianfu ZHANG
Affiliations
  • Department of Geriatrics, Lishui Branch of Zhongda Hospital Affiliated to Southeast University, Nanjing 211299, Jiangsu Province, China
Published: 2023-05-10 doi: 10.13683/j.wph.2023.05.016
Outline
收藏切换
Objective

To retrospectively analyze the effects of different doses of rivaroxaban on renal function outcome and prognosis in elderly patients with atrial fibrillation (AF) combined with stable coronary artery disease (SCAD).

Methods

A total of 416 elderly (≥65 years old) AF-SCAD patients who received rivaroxaban treatment (≥3 months) in our hospital from January to December 2018 were retrospectively analyzed, and divided into low-dose group (<10 mg/d), conventional-dose group (10 - 15 mg/d) and high-dose group (20 mg/d) according to the initial dose. The primary effective end points of treatment included cardiovascular death, myocardial infarction, ischemic stroke/transient ischemic attack, pulmonary embolism and deep venous thrombosis of the lower extremities. The primary safety end points were bleeding events and acute kidney disease (AKD).

Results

There were statistically significant differences in baseline creatinine clearance and medication time of rivaroxaban among the three groups (P<0.05). The incidence of AKD in the high-dose group was higher than that in the low-dose group during follow-up (P<0.05). Univariate and multivariate logistic regression analysis showed that after adjusting the time of administration of rivaroxaban and the initial serum creatinine clearance, rivaroxaban 20 mg/d was still an independent risk factor for AKD in patients with AF-SCAD (odds rate=3.579, 95% confidence interval: 1.879 -9.974), and also the independent risk factor for AKD in patients with baseline serum creatinine clearance of 50 - 79ml/min or ≥80ml/min (odds rate=6.876, 95% confidence interval: 2.647 - 14.652, odds rate=2.159, 95% confidence interval: 1.042 - 5.477). In addition, for patients with baseline serum creatinine clearance of 50 - 79ml/min, the conventional dose of rivaroxaban (10 - 15 mg/d) also increase the risk of AKD in patients with AF-SCAD (odds rate=1.254, 95% confidence interval: 1.001 - 1.959).

Conclusion

Rivaroxaban 20 mg/d can increases AKD risk in elderly patients with AF-SCAD and received percutaneous coronary intervention.

atrial fibrillation  /  stable coronary artery disease  /  rivaroxaban  /  renal function  /  renal function impairment
褚玉会, 左耀武, 张殿福. 回顾性分析利伐沙班对老年心房颤动合并稳定性冠状动脉粥样硬化性心脏病患者结局的影响. 世界临床药物, 2023 , 44 (5) : 499 -505 . DOI: 10.13683/j.wph.2023.05.016
Yuhui CHU, Yaowu ZUO, Dianfu ZHANG. Retrospectively analysis on rivaroxaban on outcomes of in elderly patients with atrial fibrillation and stable coronary artery disease[J]. World Clinical Drug, 2023 , 44 (5) : 499 -505 . DOI: 10.13683/j.wph.2023.05.016
Year 2023 volume 44 Issue 5
14
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.05.016
  • Receive Date:2022-09-02
  • Online Date:2026-11-18
  • Published:2023-05-10
Article Data
Affiliations
History
  • Received:2022-09-02
Funding
Affiliations
    Department of Geriatrics, Lishui Branch of Zhongda Hospital Affiliated to Southeast University, Nanjing 211299, Jiangsu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.05.016
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT